Federal Register / Vol. 70, No.
187 / Wednesday, September 28, 2005 / Notices
with the Committee by forwarding his/her
statement to the contact person listed on this
notice. The statement should include the
name, address, telephone number, and, when
applicable, the business or professional
affiliation of the interested person.
Information about the meeting and online
registration forms are also available online on
the NIMH homepage at http://
www.nimh.nih.gov/autismiacc/index.cfm.
Dated: September 21, 2005.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 05–19377 Filed 9–27–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (U.S.C. Appendix 2), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, SBIR
Topics 200 (Phase II) and 201 (Phase II),
Date: October 19, 2005.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6130
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Joyce C. Pegues, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., 7149,
Bethesda, MD 20892, 301/594–1286,
peguesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
VerDate Aug<31>2005 16:02 Sep 27, 2005 Jkt 205001
56725
Dated: September 21, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–19382 Filed 9–27–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(C)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Initial Review Group.
Date: October 20–21, 2005.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Jeffrey M. Chernak, PhD.,
Scientific Review Administrator, Office of
Review, National Institute of Nursing
Research, 6701 Democracy Plaza, Suite 712,
MSC 4870, Bethesda, MD 20817; (301) 402–
6959, chernak@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: September 21, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–19380 Filed 9–27–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 E:\FR\FM\28SEN1.SGM
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Initial Review Group,
Medication Development Research
Subcommittee.
Date: October 5, 2005.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Paul A. Coulis, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6101 Executive Boulevard, Suite 220,
Bethesda, MD 20892–8401, 301–443–2105.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Health
Services Research Subcommittee.
Date: October 6–7, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS Room 220, MSC
8401, 6101 Executive Blvd., Bethesda, MD
20892–8401, 301–402–6626, gm145@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Treatment
Research Subcommittee.
Date: October 6–7, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kesinee Nimit, MD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401, 301–435–1432.
This notice is being published less than 15
days prior to the meeting due to the timing
28SEN1
 56726 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Centers
Review Meeting.
Date: October 24, 2005.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, 301–
435–1388.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Training
and Career Development Subcommittee.
Date: November 1–3, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive
Boulevard, Room 220, MSC 8401, Bethesda,
MD 20892–8401, 301–451–4530,
el6r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Developent Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: September 21, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–19381 Filed 9–27–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings
The meetings will be closed to the
public in accordance with the
provisions set forth in sections 552(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
VerDate Aug<31>2005 16:02 Sep 27, 2005 Jkt 205001
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Mechanism For Time-Sensitive Research
Opportunities.
Date: October 11, 2005.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: A. Roger Little, PhD.,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6157, MSC 9609,
Rockville, MD 20852–9609, 301–402–5844,
alittle@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel, ITV
Conflicts.
Date: October 21, 2005.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Tracy Waldeck, PhD.,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Blvd., Room 6132, MSC 9608,
Bethesda, MD 20892–9608, 301–435–0322,
waldeckt@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel
CIDAR.
Date: October 27–28, 2005.
Time: 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn—Silver Spring, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Peter J. Sheridan, PhD.,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Blvd., Room 6142, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1513,
psherida@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
National Research Service Award
Institutional Research Training.
Date: November 2, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Summerfield Suites by Wyndham,
200 Skidmore Boulevard, Chesapeake Room,
Gaithersburg, MD 20877.
Contact Person: A. Roger Little, Phd,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 E:\FR\FM\28SEN1.SGM
6001 Executive Blvd., Room 6157, MSC 9609,
Rockville, MD 20852–9609, 301–402–5844,
alittle@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Building Translational Research in
Behavioral Science, Panel 1.
Date: November 3, 2005.
Time: 9:45 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Peter J. Sheridan, Phd,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6142, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1513,
psherida@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Building Translational Research in
Behavioral Science, Panel 2.
Date: November 4, 2005.
Time: 2 p.m. to 3:10 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Peter J. Sheridan, Phd,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6142, MSC 9606,
Bethesda, MD 20892–1513,
psherida@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Mental Health Dissertation.
Date: November 10, 2005.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Serena P. Chu, Phd,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6154, MSC 9609,
Rockville, MD 20892–9609, 301–443–0004,
sechu@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel, SRV
Conflicts.
Date: November 14, 2005.
Time: 12:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Serena P. Chu, Phd,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6154, MSC 9609,
28SEN1